🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In Opinion Charles M. Blow writes, "Staying at home is a privilege. Social distancing is a privilege. The people who can’t must make terrible choices: Stay home and risk starvation or go to work and risk contagion." nyti.ms/2XemRNp

New York City witnessed zero confirmed deaths due to coronavirus on Wednesday. It's the first day without a COVID-19 death in months. nydailynews.com/coronavirus/ny…

Making memories with our amazing graduates and Elmhurst faculty on a beautiful Sunday afternoon 🌤🥰

🎓Congrats to our graduating fellows! Thank you for your endless support, teaching, and friendship - not to mention your time at the COVID epicenter during the height of the pandemic. The future of cardiology is bright 😎 Imad Bagh @M_CagliostroMD Eman R. Rashed, MD, PhD dsternheim

Casually running into my favorite Heart Failure fellow Eman R. Rashed, MD, PhD and former @RutgersIMRes chief! Penn Cardiology is lucky to have you!! Penn Women in Cardiology

Mark your 🗓️❗Our next #CME, taking place on 10/21-22, will provide a comprehensive update on the management of #heartfailure focusing on the recently updated ACC/AHA HF Management Guidelines. Learn more & register ⬇️ upenn.cloud-cme.com/course/courseo… #MedEd #CardioTwitter

#TurkeyEarthquake #TurkeySyriaEarthquake2023 #turkeyearthquakerelief Help unites us

Happy International Women’s Day! #EmbraceEquity Women As One Rosy Thachil, MD, MBA Isha Ranadive, MD MPH Eman R. Rashed, MD, PhD @SonikaPatel18 Gayatri Setia, MD SeoNg Catherine Duazo Lindsay Elbaum, MD, FACC, FSCAI Panagiota Christia Tania Ruiz Maya, MD 🥰

Amazing talk by Dr. Lynn Punnoose 🫀 and 🫁 transplant in🤰#ISHLT2023 Women in Heart Transplantation and MCS 📌🤰co-morbidities: HTN, pre-eclampsia, infection ➡️ risk stratify 📌 Timing ❗️ >1-2 yrs, stable graft, no rejection 12 mo 📌 planned approach 🛑 teratogenic 💊 📌 frequent 🫀🫁 surveillance 🤰

CTRCD is one of the most feared side effects of cancer treatment, occurring in approximately 10% of patients. A new study aims to validate cardiotoxicity risk assessment guidelines. ➡️ spr.ly/6016uI6Sk @Emanrashed01 The Penn Thalheimer Center for Cardio-Oncology #CardioOncology